Rapport Therapeutics (RAPP) Stock Chart & Stock Price History $14.88 -0.07 (-0.44%) As of 03:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Rapport Therapeutics Stock Price Performance The Rapport Therapeutics (RAPP) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 26.20%, with a year-to-date return of -15.22%. In the past month, the stock has increased 4.59%, reflecting recent market activity. As of the latest close, Rapport Therapeutics traded at $14.94 with a market cap of $545.28 million and volume of 109,059 shares. Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.37%1 Month Performance+4.59%3 Month Performance+54.10%Year-To-Date Performance-15.22%1 Year Performance-26.20% RAPP Stock Chart for Friday, August, 15, 2025 RAPP Chart by TradingView Rapport Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/14/2025$15.60$14.94-4.23%$15.44$14.70109,059 shs$545.28 million08/13/2025$15.54$15.60+0.39%$16.13$15.42145,383 shs$569.40 million08/12/2025$14.34$15.54+8.34%$15.87$14.28213,509 shs$567.21 million08/11/2025$14.55$14.34-1.42%$15.49$14.09165,822 shs$523.53 million08/08/2025$15.41$14.55-5.58%$16.00$14.55104,519 shs$531.08 million08/07/2025$14.61$15.41+5.48%$15.60$13.62334,257 shs$562.43 million08/06/2025$14.43$14.61+1.25%$15.88$14.03107,424 shs$533.27 million08/05/2025$14.04$14.43+2.78%$15.20$13.87206,792 shs$526.70 million08/04/2025$14.15$14.04-0.78%$14.88$13.93143,799 shs$512.43 million08/01/2025$14.36$14.15-1.46%$15.06$13.88124,280 shs$516.45 million Get the Latest News and Ratings for RAPP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/31/2025$14.83$14.36-3.17%$15.75$14.16115,222 shs$524.14 million07/30/2025$15.42$14.83-3.83%$15.94$14.42122,920 shs$541.30 million07/29/2025$16.74$15.42-7.89%$17.05$15.30213,219 shs$562.80 million07/28/2025$16.05$16.74+4.30%$17.45$15.82136,616 shs$611.01 million07/25/2025$16.62$16.05-3.43%$16.74$15.44138,147 shs$585.83 million07/24/2025$15.50$16.62+7.23%$17.24$15.20188,703 shs$606.63 million07/23/2025$15.20$15.50+1.97%$15.72$14.86166,390 shs$565.72 million07/22/2025$14.39$15.20+5.63%$15.22$14.10199,905 shs$554.80 million07/21/2025$14.68$14.39-1.98%$15.89$14.34151,103 shs$525.24 million07/18/2025$14.84$14.68-1.08%$15.91$14.52137,409 shs$535.82 million07/17/2025$15.22$14.84-2.50%$16.32$14.60215,146 shs$541.63 million07/16/2025$14.38$15.22+5.84%$15.36$14.24141,978 shs$555.53 million07/15/2025$14.63$14.38-1.71%$15.06$13.43180,924 shs$524.87 million07/14/2025$14.60$14.63+0.21%$15.30$14.17143,468 shs$534.00 million Related Companies AGIO Stock Chart DNLI Stock Chart IDYA Stock Chart TARS Stock Chart IRON Stock Chart HRMY Stock Chart MESO Stock Chart CGON Stock Chart ADPT Stock Chart VCEL Stock Chart Receive RAPP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Rapport Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RAPP) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rapport Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rapport Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access